Materias dentro de su búsqueda.
Mostrando 173,521 - 173,540 Resultados de 174,586 Para Buscar '"'39"', tiempo de consulta: 1.06s Limitar resultados
  1. 173521
    “…FINDINGS: Between Dec 1, 2016, and Feb 8, 2019, 590 patients were recruited and randomly assigned, with 294 allocated to peer support (287 included in the analysis after withdrawals and loss to follow-up), and 296 to care as usual (291 in the analysis). Mean age was 39·7 years (SD 13·7; range 18–75). 306 patients were women, 267 were men, three were transgender, and two preferred not to say. 353 patients were White, 94 were Black, African, Caribbean, or Black British, 68 were Asian or Asian British, 48 were of mixed or multiple ethnic groups, and 13 were of other ethnic groups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Peer support for discharge from inpatient mental health care versus care as usual in England (ENRICH): a parallel, two-group, individually randomised controlled trial
  2. 173522
    “…The identified determinants of unmet need for family planning was 30–39 years (AOR = 0.7; 95% CI 0.54–0.91), age of 40–49 (AOR = 0.76; 95% CI 0.58–0.99), rural residence (AOR = 1.17; 95% CI 1.02–1.34), female household head (AOR = 0.66; 95% CI 0.61–0.73), women having 4–6 child (AOR = 1.76; 95% CI 1.55–1.99), women having 7–9 child (AOR = 2.77; 95% CI 2.34–3.28) women having ≥10 child (AOR = 3.51; 95% CI 2.58–4.78), women who give their first birth 19-25 years (AOR = 1.1; 95% CI 1.0–1.26), 26–34 years (AOR = 1.4; 95% CI 1.19–1.83) ≥35 years (AOR = 2.1; 95% CI 1.1–4.27) and no fertility desire (AOR = 1.52; 95% CI 1.36–1.67) were the determinants of unmet need for family planning in east Africa. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Magnitude and determinants of unmet need for family planning among reproductive age women in East Africa: multilevel analysis of recent demographic and health survey data
  3. 173523
    “…The overall SRH service utilization among the whole adolescents was 39.5% (95%CI: 36.5, 42.4). There was a significant difference in SRH service utilization between urban 56.9% (95%CI: 51.8, 62.1) and rural 30.8% (95%CI: 27.4, 34.2) adolescents (χ2 = 68.3, p < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Disparities in sexual and reproductive health services utilization among urban and rural adolescents in southern Ethiopia, 2020: a comparative cross-sectional study
  4. 173524
    “…These species are found in 8 Chinese zoogeographical regions: The Taiwan region is the most diversified with 161 species and the highest rate of endemic species (69.57%), followed by South China (78 species, 17.95%), Central China (60 species, 33.33%), Southwest China (43 species, 39.53%), North China (29 species, 34.48%), Qinghai-Tibet region (10 species, 20%), Northeast China (8 species, 12.5%), and 5 species found in the Inner Mongolia-Xinjiang region that are not endemic ones. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Distribution patterns of Chinese Cixiidae (Hemiptera, Fulgoroidea), highlight their high endemic diversity
  5. 173525
    “…Age (OR 1.063, 95%CI: 1.005-1.12, P = 0.032), arterial hypertension (3.593, 95%CI: 1.06-12.19, P = 0.04) and global (2.44, 95%CI: 0.27-0.88, P = 0.019), digestive (OR 4,23, 95%CI: 1.27-14.07, P = 0.019) and neurological (OR 4.66, 95%CI: 1.39-15.62, P = 0.013) complications during ECMO therapy were independent predictors of primary endpoint occurrence. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oxigenación con membrana extracorpórea en el paciente COVID-19: resultados del Registro Español ECMO-COVID de la Sociedad Española de Cirugía Cardiovascular y Endovascular
  6. 173526
    “…Treatment with baricitinib significantly reduced 28-day all-cause mortality compared with placebo (20 [39%] of 51 participants died in the baricitinib group vs 29 [58%] of 50 in the placebo group; hazard ratio [HR] 0·54 [95% CI 0·31–0·96]; p=0·030; 46% relative reduction; absolute risk reduction 19%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
  7. 173527
    “…Preoperatively, OPIOID reported greater NRS back pain (7.7 vs 6.7) and leg pain (5.2 vs 3.9), worse ODI (50.8 vs 36.9), worse SF-36 PCS (28.8 vs 35.6), and worse SRS-22r self-image (2.3 vs 2.5) than NON, respectively (p<0.05). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Opioid use prior to surgery is associated with worse preoperative and postoperative patient reported quality of life and decreased surgical cost effectiveness for symptomatic adult spine deformity; A matched cohort analysis
  8. 173528
    “…During the study period, female youth ice hockey players increased significantly from 44,678 in 2007 to 57,792 in 2016 (p=3.9x10-5, R-squared=0.89, ß =0.94). The overall number of injuries, however, only slightly increased from 992 in 2007 to 1,042 in 2016 (p=ns). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of Female Youth Ice Hockey Injuries Presenting to United States Emergency Department’s from 2007 to 2016
  9. 173529
    “…At the COVID-19 impact survey timepoint, a higher proportion of mothers had clinically significant depression (35·21%, 95% CI 32·48–38·04) and anxiety symptoms (31·39%, 28·76–34·15) than at all previous data collection timepoints. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Maternal depressive and anxiety symptoms before and during the COVID-19 pandemic in Canada: a longitudinal analysis
  10. 173530
    “…At the end of 6 months, the PPT intervention leads to significant improvements in multiple metabolic health parameters, among them HbA1c (mean ± SD, − 0.39 ± 0.48%, p < 0.001), fasting glucose (− 16.4 ± 24.2 mg/dl, p = 0.02) and triglycerides (− 49 ± 46 mg/dl, p < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial
  11. 173531
    “…RESULTADOS: A faixa etária mais prevalente para todas as mulheres foi a de 20 e 39 anos (7.622; 85,5%) e a cor branca (7.482; 83,9%). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ANÁLISE TEMPORAL DOS CASOS DE COVID-19 EM MULHERES GESTANTES E NÃO GESTANTES DO ESTADO DO RIO GRANDE DO SUL: UMA COMPARAÇÃO ENTRE COMORBIDADES E DESFECHOS
  12. 173532
    “…Quanto à idade, as negras maiores de 60 anos tiveram 4,26 vezes mais chance de morrer, OR = 4,26 IC95% (3,9-4,6), do que as negras 20 a 60 anos. Negras maiores de 60 anos tiveram 1,26 vezes mais chance de morrer, OR = 1,26 IC95% (1,18-1,34) do que brancas na mesma faixa. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ANÁLISE DO PERFIL RACIAL DE MULHERES COM COVID-19: ESTUDO TRANSVERSAL SOBRE EVOLUÇÃO A ÓBITO DE MULHERES NEGRAS NA REGIÃO SUDESTE
  13. 173533
    por Fabiani, Massimo, Puopolo, Maria, Morciano, Cristina, Spuri, Matteo, Spila Alegiani, Stefania, Filia, Antonietta, D’Ancona, Fortunato, Del Manso, Martina, Riccardo, Flavia, Tallon, Marco, Proietti, Valeria, Sacco, Chiara, Massari, Marco, Da Cas, Roberto, Mateo-Urdiales, Alberto, Siddu, Andrea, Battilomo, Serena, Bella, Antonino, Palamara, Anna Teresa, Popoli, Patrizia, Brusaferro, Silvio, Rezza, Giovanni, Menniti Ippolito, Francesca, Pezzotti, Patrizio, Boros, Stefano, Rota, Maria Cristina, Bressi, Marco, Vescio, Maria Fenicia, Petrone, Daniele, Di Benedetto, Corrado, Ciervo, Alessandra, Stefanelli, Paola, Petrucci, Antonia, La Bianca, Michele, Mignuoli, Anna Domenica, Buono, Pietro, Massimiliani, Erika, Barbone, Fabio, Vairo, Francesco, Sticchi, Camilla, Cereda, Danilo, Di Furia, Lucia, Sforza, Francesco, Bassot, Annamaria, Benetollo, Pier Paolo, Pasqualini, Chiara, Bisceglia, Lucia, Palmas, Maria Antonietta, Scondotto, Salvatore, Balocchini, Emanuela, Tosti, Anna, Ruffier, Mauro, Da Re, Filippo, Odio, Camillo, Recine, Michele, Ruberto, Innocenza, Bisogno, Salvatore Ascione, Massimo, Miserendino, Gandolfo, Navacchia, Massimiliano, Del Frate, Beatrice, Cau, Emanuela, Baiocchi, Diego, Fusco, Danilo, Gallo, Domenico, Marchetti, Maria Rosa, Spazzafumo, Liana, Malatesta, Raffaele, Fanolla, Antonio, Conforti, Diego, Trentini, Carlo, Ruggeri, Antonino, Ladalardo, Concetta, Albano, Nehludoff, Corona, Marco, Lombardi, Paolo, Iacono, Massimo, Angori, Paolo Bruno, Belardinelli, Andrea, Solfiti, Milena, Fioraso, Stefano, Poma, Chiara, Raccanello, Nadia
    Publicado 2022
    “…RESULTS: During the epidemic phase when the delta variant was the predominant strain of the SARS-CoV-2 virus, vaccine effectiveness against SARS-CoV-2 infection significantly decreased (P<0.001) from 82% (95% confidence interval 80% to 84%) at 3-4 weeks after the second dose of vaccine to 33% (27% to 39%) at 27-30 weeks after the second dose. In the same time intervals, vaccine effectiveness against severe covid-19 also decreased (P<0.001), although to a lesser extent, from 96% (95% to 97%) to 80% (76% to 83%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
  14. 173534
    por Elkrief, Arielle, Hennessy, Cassandra, Kuderer, Nicole M, Rubinstein, Samuel M, Wulff-Burchfield, Elizabeth, Rosovsky, Rachel P, Vega-Luna, Karen, Thompson, Michael A, Panagiotou, Orestis A, Desai, Aakash, Rivera, Donna R, Khaki, Ali Raza, Tachiki, Lisa, Lynch, Ryan C, Stratton, Catherine, Elias, Rawad, Batist, Gerald, Kasi, Anup, Shah, Dimpy P, Bakouny, Ziad, Cabal, Angelo, Clement, Jessica, Crowell, Jennifer, Dixon, Becky, Friese, Christopher R, Fry, Stacy L, Grover, Punita, Gulati, Shuchi, Gupta, Shilpa, Hwang, Clara, Khan, Hina, Kim, Soo Jung, Klein, Elizabeth J, Labaki, Chris, McKay, Rana R, Nizam, Amanda, Pennell, Nathan A, Puc, Matthew, Schmidt, Andrew L, Shahrokni, Armin, Shaya, Justin A, Su, Christopher T, Wall, Sarah, Williams, Nicole, Wise-Draper, Trisha M, Mishra, Sanjay, Grivas, Petros, French, Benjamin, Warner, Jeremy L, Wildes, Tanya M
    Publicado 2022
    “…The CCC19 geriatric risk index identified 2365 (41·7%) patients as standard risk, 2217 (39·1%) patients as intermediate risk, and 1089 (19·2%) as high risk. 36 (0·6%) patients were excluded due to non-calculable geriatric risk index. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium
  15. 173535
    “…MAIN RESULTS AND THE ROLE OF CHANCE: Transfer of a blastocyst with a low overall grading was associated with a higher chance of female baby (48% vs 42%, adjusted OR = 1.26 (1.13, 1.39)) and a higher rate of caesarian section (C-section; 71% vs 68%, adjusted OR = 1.15 (1.02, 1.29)). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Blastocyst quality and perinatal outcomes in women undergoing single blastocyst transfer in frozen cycles
  16. 173536
    “…Absolute and relativized peak oxygen uptake (VO(2 peak); ER 4120 ± 750 ml/min (39 ± 5.4 ml/kg/min) vs. non-ER 3556 ± 393 ml/min (37.2 ± 5.3 ml/kg/min), p = 0.018) and maximum workload during CPET (ER 310 ± 51.5 Watt (2.94 ± 0.35 W/kg) vs. non-ER 271 ± 32 Watt (2.85 ± 0.49 W/kg), p = 0.026) was higher in athletes with an ER pattern. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Electrical and Structural Adaption of Athlete’s Heart and the Impact on Training and Recovery Management in Professional Basketball Players: A Retrospective Observational Study
  17. 173537
    “…Holding other factors constant, the risk of severe breakthrough infection was most strongly associated with age older than 80 years (adjusted odds ratio 1·76, 95% CI 1·43–2·15), vaccine type (Pfizer 1·39, 0·98–1·97; Janssen 14·53, 8·43–25·03; both relative to Moderna), time since vaccination (1·05, 1·03–1·07; per week after week 8 when protection peaks, technically), and comorbidities including organ transplantation (3·44, 95% CI 2·12–5·57), cancer (1·93, 1·60–2·33), and immunodeficiency (1·49, 1·13–1·96). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study
  18. 173538
    “…The 2-year cumulative incidence of cGVHD was 39.5% (95% CI, 29.3–49.4%) and 62.7% (51.4–72.1%) in the MSC and control groups (HR 0.55, 95% CI, 0.36–0.84; P = 0.005). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
  19. 173539
    “…In the Lanzhou center, CBD diameter and choledocholithiasis size were lower, and multiple CBD stones and acute cholangitis were less in non-PAD patients than those in PAD patients (13.4 ± 5.1 mm vs 14.8 ± 5.2 mm, 10.3 ± 5.4 mm vs 12.2 ± 6.5, 39% vs 45.3%, 13.9% vs 18.5%, P = 0.002 to < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Choledocholithiasis characteristics with periampullary diverticulum and endoscopic retrograde cholangiopancreatography procedures: Comparison between two centers from Lanzhou and Kyoto
  20. 173540
    “…Among ChAdOx1 nCoV-19 primary course recipients, vaccine effectiveness increased to 62.4% (95% CI, 61.8 to 63.0) at 2 to 4 weeks after a BNT162b2 booster before decreasing to 39.6% (95% CI, 38.0 to 41.1) at 10 or more weeks. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Herramientas de búsqueda: RSS